NasdaqCM - Delayed Quote USD
Lipella Pharmaceuticals Inc. (LIPO)
2.4100
+0.0150
+(0.63%)
At close: 4:00:01 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| CHANCELLOR MICHAEL B. Officer, Director and Beneficial Owner | Stock Award(Grant) | Mar 13, 2024 | 877,637 |
| KAUFMAN JONATHAN Chief Executive Officer | Purchase | May 14, 2024 | 898,849 |
Related Tickers
OBIO Orchestra BioMed Holdings, Inc.
2.8500
-0.35%
MLEC Moolec Science SA
0.6145
-9.65%
TNFA TNF Pharmaceuticals, Inc.
0.1881
+5.73%
MTVA MetaVia Inc.
0.8130
+8.40%
OSTX OS Therapies Incorporated
1.5500
+1.97%
CMND Clearmind Medicine Inc.
0.9764
-2.36%
SLGL Sol-Gel Technologies Ltd.
0.7002
+17.29%
AVTE Aerovate Therapeutics, Inc.
2.7400
-0.72%
GLTO Galecto, Inc.
2.7500
+2.61%
BDRX Biodexa Pharmaceuticals Plc
1.4200
0.00%